Barclays PLC Schedule 13G passive stakes

Barclays PLC has filed a Schedule 13G reporting a 5.75% beneficial ownership stake in Mercer International Inc.

Barclays PLC has filed a Schedule 13G reporting a 5.96% beneficial ownership stake in Reviva Pharmaceuticals Holdings, Inc.

Barclays PLC has filed a Schedule 13G reporting a 6.32% beneficial ownership stake in Bel Fuse Inc. Class A common stock.

Barclays PLC has filed a Schedule 13G reporting a 6.39% beneficial ownership stake in Gores Holdings X Inc. Class A common stock.

Barclays PLC has filed a Schedule 13G reporting a 7.00% beneficial ownership stake in Andretti Acquisition Corp A.

Barclays PLC has filed a Schedule 13G reporting a 7.00% beneficial ownership stake in Graf Global Corp common stock.

Barclays PLC has filed a Schedule 13G reporting a 7.00% beneficial ownership stake in SilverBox Corp IV-A.

Barclays PLC has filed a Schedule 13G reporting a 7.46% beneficial ownership stake in Calisa Acquisition Corp.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership stake in Centurion Acquisition Corp.

Barclays PLC has filed an amendment to its Schedule 13G, reporting beneficial ownership of 19,901 shares of WEN Acquisition Corp common stock.

Barclays PLC has filed a Schedule 13G disclosing a 1.27% beneficial ownership stake in Phibro Animal Health Corp.

Barclays PLC has filed a Schedule 13G reporting a 1.61% beneficial ownership stake in James River Group Holdings.

Barclays PLC has filed a Schedule 13G reporting a 3.56% beneficial ownership stake in Cantor Equity Partners Class A common stock.

Barclays PLC has filed a Schedule 13G reporting beneficial ownership of 3.60% of Melar Acquisition Corp I-A common stock.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a 3.70% beneficial ownership stake in Shenandoah Telecommunication.

Barclays PLC has filed a Schedule 13G reporting a 4.40% beneficial ownership stake in SoulPower Acquisition Co-A.

Barclays PLC has filed a Schedule 13G reporting a 4.61% beneficial ownership stake in RADCOM Ltd as of March 31, 2026.

Barclays PLC has filed a Schedule 13G reporting a 4.94% beneficial ownership stake in Vine Hill Capital Class A common stock.

Barclays PLC has filed a Schedule 13G reporting a 5.05% beneficial ownership stake in Lakeshore Acquisition III Corp.

Barclays PLC has filed a Schedule 13G reporting a 5.12% beneficial ownership stake in Madison Square Garden Entertainment Corp.

Barclays PLC has filed a Schedule 13G reporting a 5.23% beneficial ownership stake in CO2 Energy Transition Corp.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 5.02% of Everspin Technologies Inc. common stock as of March 31, 2026.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership in Blue Water Acquisition C-A as of December 31, 2025.

Barclays PLC has reported a 0% beneficial ownership in Lightwave Acquisition Corp-A, indicating a full divestment of its previously reportable stake.

Barclays PLC has filed an amended Schedule 13G, indicating it no longer beneficially owns any common stock in Launch One Acquisition Corp.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a complete divestment of its beneficial ownership in GIGCAPITAL7 CORP-A, now holding 0% of common stock.

Barclays PLC has filed an amended Schedule 13G, reporting a 0% beneficial ownership in DT Cloud Star Acquisition Co.

Barclays PLC has reported a 6.9% beneficial ownership stake in Bleichroeder Acquisition Corp, holding over 1.75 million common shares.

Barclays PLC has filed an amended Schedule 13G, revealing a 6.95% beneficial ownership stake in RADCOM LTD as of December 31, 2025.

Barclays PLC has filed an amended Schedule 13G, disclosing a 4.98% passive ownership stake in Willow Lane Acquisition-CL A as of December 31, 2025.